Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.21.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Income Statement [Abstract]    
Revenue $ 39,714,000 $ 33,633,000
Cost of revenue 33,390,000 28,902,000
Gross profit 6,324,000 4,731,000
Operating expenses:    
Research and development 2,868,000 2,810,000
Sales and marketing 2,859,000 3,743,000
General and administrative 10,602,000 7,759,000
Total operating expenses 16,329,000 14,312,000
Loss from operations (10,005,000) (9,581,000)
Other income, net 45,000 42,000
Financial expense, net (719,000) (41,000)
Foreign currency income 355,000 168,000
Loss before income tax expense (benefit) (10,324,000) (9,412,000)
Income tax expense (benefit) 34,000 (589,000)
Net loss $ (10,358,000) $ (8,823,000)
Net loss per common share, basic and diluted $ (0.34) $ (0.44)
Weighted-average shares used in computing net loss per common share, basic and diluted 30,364,943 19,979,589